Alzheimer's disease apolipoprotein pathology for treatment elucidation and development
Project factsheets
The Innovative Health Initiative builds on the successes of the Innovative Medicines Initiative (IMI), which launched over 180 projects. Many IMI projects are still ongoing and are monitored by the IHI Programme Office. This section features the factsheets of all IMI projects. Once IHI projects are up and running, we will also promote them here.
Displaying 14 projects/programmes
Applied public-private research enabling osteoarthritis clinical headway
Corona accelerated R&D in Europe
European screening centre; unique library for attractive biology
EUbOPEN: Enabling and unlocking biology in the OPEN
Inhibiting misfolded protein propagation in neurodegenerative diseases
Modern approaches for developing antivirals against SARS-CoV 2
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
Psychiatric ratings using intermediate stratified markers 2
Research empowerment on solute carriers
Add medical genetic solutions to RESOLUTE (REsolution)
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs
